Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b

By  

Current Pharmaceutical Design, Vol. 8, Iss. 24, 2002-11 ,pp. : 2139-2157

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C

By Jansen Peter LM   De Bruijne Joep  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats

By Badkar Advait   Smith Alan   Eppstein Jonathan   Banga Ajay  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1389-1395

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

ALTERED UTERINE SENSITIVITY TO OXYTOCIN AND PROSTAGLANDIN F 2alpha IN DIMETHYLBENZ(a)ANTHRACENE (DMBA)-INDUCED RAT MAMMARY CARCINOMA: THE EFFECTS OF TAMOXIFEN AND/OR RECOMBINANT HUMAN INTERFERON alpha2b THERAPY

By Badary O.A.   Agha A.M.   El-Sayed E.S.M.   Hamada F.M.A.  

Pharmacological Research, Vol. 34, Iss. 3, 1996-09 ,pp. : 99-103

Academic Press

Access to resources Recommend Favorite